LAG3 showed a protective effect in AML, ovarian cancer, and breast cancer, while in bladder cancer (transitional cell carcinoma) and breast and brain cancer (glioma), it presented an adverse prognostic role. The gene discussed is LAG3; the disease is ovarian cancer.